IGF1 and neoplasm: The overall efficacy of SSA is ~35% in biochemical remission rate (mean GH levels < 2.5 μg/L and IGF-1 normalization) [2, 3] and ~70% in oncological response rate (tumor volume shrinkage > 20%) [4, 5].